{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:22:37Z","timestamp":1780507357494,"version":"3.54.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s12020-011-9553-3","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T16:04:07Z","timestamp":1320249847000},"page":"31-39","source":"Crossref","is-referenced-by-count":13,"title":["Primary aldosteronism: from bench to bedside"],"prefix":"10.1007","volume":"41","author":[{"given":"Norlela","family":"Sukor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"9553_CR1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF02158515","volume":"10","author":"SA Simpson","year":"1954","unstructured":"S.A. Simpson, J.F. Tait, A. Wettstein, R. Neher, J. Von Euw, O. Schindler, T. Reichstein, Constitution of aldosterone, a new mineralocorticoid. Experientia 10, 132\u2013133 (1954)","journal-title":"Experientia"},{"key":"9553_CR2","first-page":"257","volume":"62","author":"JW Conn","year":"1966","unstructured":"J.W. Conn, The evolution of primary aldosteronism: 1954\u20131967. Harvey Lect. 62, 257\u2013291 (1966)","journal-title":"Harvey Lect."},{"key":"9553_CR3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"P. Milliez, X. Girerd, P.F. Plouin, J. Blacher, M.E. Safar, J.J. Mourad, Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol. 45, 1243\u20131248 (2005)","journal-title":"J. Am. Coll. Cardiol."},{"key":"9553_CR4","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","volume":"90","author":"M Stowasser","year":"2005","unstructured":"M. Stowasser, J. Sharman, R. Leano, R.D. Gordon, G. Ward, D. Cowley, T.H. Marwick, Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J. Clin. Endocrinol. Metab. 90, 5070\u20135076 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9553_CR5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"C. Catena, G. Colussi, E. Nadalini, A. Chiuch, S. Baroselli, R. Lapenna, L.A. Sechi, Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch. Intern. Med. 168, 80\u201385 (2008)","journal-title":"Arch. Intern. Med."},{"key":"9553_CR6","first-page":"1109","volume":"95","author":"DJ Sutherland","year":"1966","unstructured":"D.J. Sutherland, J.L. Ruse, J.C. Laidlaw, Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can. Med. Assoc. J. 95, 1109\u20131119 (1966)","journal-title":"Can. Med. Assoc. J."},{"key":"9553_CR7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"R.P. Lifton, R.G. Dluhy, M. Powers, G.M. Rich, S. Cook, S. Ulick, J.M. Lalouel, A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355, 262\u2013265 (1992)","journal-title":"Nature"},{"key":"9553_CR8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/bbrc.1995.1225","volume":"207","author":"JR Jonsson","year":"1995","unstructured":"J.R. Jonsson, S.A. Klemm, T.J. Tunny, M. Stowasser, R.D. Gordon, A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem. Biophys. Res. Commun. 207, 565\u2013571 (1995)","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"9553_CR9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","volume":"18","author":"RD Gordon","year":"1991","unstructured":"R.D. Gordon, M. Stowasser, T.J. Tunny, S.A. Klemm, W.L. Finn, A.L. Krek, Clinical and pathological diversity of primary aldosteronism, including a new familial variety. Clin. Exp. Pharmacol. Physiol. 18, 283\u2013286 (1991)","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"9553_CR10","unstructured":"Jeskey Y, So A, Gordon RD, Duffy D, Kelemen L, Bulmer B, Stowasser M, Genetic Basis of familial hyperaldosteronism type II: further evidence of linkage at chromosome 7p22. In: Hypertension. 28th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Brisbane, Australia, 49, 1477 (2007)"},{"key":"9553_CR11","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/HJH.0b013e3283028352","volume":"26","author":"N Sukor","year":"2008","unstructured":"N. Sukor, P. Mulatero, R.D. Gordon, A. So, D. Duffy, C. Bertello, L. Kelemen, Y. Jeske, F. Veglio, M. Stowasser, Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J. Hypertens. 26, 1577\u20131582 (2008)","journal-title":"J. Hypertens."},{"key":"9553_CR12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1440-1681.2008.04882.x","volume":"35","author":"YW Jeske","year":"2008","unstructured":"Y.W. Jeske, A. So, L. Kelemen, N. Sukor, C. Willys, B. Bulmer, R.D. Gordon, D. Duffy, M. Stowasser, Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II. Clin. Exp. Pharmacol. Physiol. 35, 380\u2013385 (2008)","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"9553_CR13","doi-asserted-by":"crossref","unstructured":"So A. Jeske YW, Kelemen L, Bulmer B, Gordon RD, Duffy D, Stowasser M, Examination of candidate genes at chromosome 7p22 in familial hyperaldosteronism type II. Hypertension, 49, 1469 (2007)","DOI":"10.1111\/j.1440-1681.2008.04882.x"},{"key":"9553_CR14","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","volume":"93","author":"DS Geller","year":"2008","unstructured":"D.S. Geller, J. Zhang, M.V. Wisgerhof, C. Shackleton, M. Kashgarian, R.P. Lifton, A novel form of human Mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J. Clin. Endocrinol. Metab. 93, 3117\u20133123 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9553_CR15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","volume":"331","author":"M Choi","year":"2011","unstructured":"M. Choi, U.I. Scholl, P. Yue, P. Bjorklund, B. Zhao, C. Nelson-Williams, W. Ji, Y. Cho, A. Patel, C.J. Men, E. Lolis, M.V. Wisgerhof, D.S. Geller, S. Mane, P. Hellman, G. Westin, G. Akerstrom, W. Wang, T. Carling, R.P. Lifton, K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331, 768\u2013772 (2011)","journal-title":"Science"},{"key":"9553_CR16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","volume":"21","author":"RD Gordon","year":"1994","unstructured":"R.D. Gordon, M. Stowasser, T.J. Tunny, S.A. Klemm, J.C. Rutherford, High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin. Exp. Pharmacol. Physiol. 21, 315\u2013318 (1994)","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"9553_CR17","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"P. Mulatero, M. Stowasser, K.C. Loh, C.E. Fardella, R.D. Gordon, L. Mosso, C.E. Gomez-Sanchez, F. Veglio, W. F. Young Jr, Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J. Clin. Endocrinol. Metab. 89, 1045\u20131050 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9553_CR18","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"G.P. Rossi, G. Bernini, C. Caliumi, G. Desideri, B. Fabris, C. Ferri, C. Ganzaroli, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, M. Mannelli, M.J. Mattarello, A. Moretti, G. Palumbo, G. Parenti, E. Porteri, A. Semplicini, D. Rizzoni, E. Rossi, M. Boscaro, A.C. Pessina, F. Mantero, A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J. Am. Coll. Cardiol. 48, 2293\u20132300 (2006)","journal-title":"J. Am. Coll. Cardiol."},{"key":"9553_CR19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","volume":"42","author":"L Mosso","year":"2003","unstructured":"L. Mosso, C. Carvajal, A. Gonzalez, A. Barraza, F. Avila, J. Montero, A. Huete, A. Gederlini, C.E. Fardella, Primary aldosteronism and hypertensive disease. Hypertension 42, 161\u2013165 (2003)","journal-title":"Hypertension"},{"key":"9553_CR20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjhyper.2005.01.002","volume":"18","author":"MK Nishizaka","year":"2005","unstructured":"M.K. Nishizaka, M. Pratt-Ubunama, M.A. Zaman, S. Cofield, D.A. Calhoun, Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. Am. J. Hypertens. 18, 805\u2013812 (2005)","journal-title":"Am. J. Hypertens."},{"key":"9553_CR21","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/dc07-0031","volume":"30","author":"GE Umpierrez","year":"2007","unstructured":"G.E. Umpierrez, P. Cantey, D. Smiley, A. Palacio, D. Temponi, K. Luster, A. Chapman, Primary aldosteronism in diabetic subjects with resistant hypertension. Diabetes Care 30, 1699\u20131703 (2007)","journal-title":"Diabetes Care"},{"key":"9553_CR22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/eje.0.1460523","volume":"146","author":"G Bernini","year":"2002","unstructured":"G. Bernini, A. Moretti, G. Argenio, A. Salvetti, Primary aldosteronism in normokalemic patients with adrenal incidentalomas. Eur. J. Endocrinol. 146, 523\u2013529 (2002)","journal-title":"Eur. J. Endocrinol."},{"key":"9553_CR23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"D.A. Calhoun, M.K. Nishizaka, M.A. Zaman, R.B. Thakkar, P. Weissmann, Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40, 892\u2013896 (2002)","journal-title":"Hypertension"},{"key":"9553_CR24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","volume":"11","author":"A Di Murro","year":"2010","unstructured":"A. Di Murro, L. Petramala, D. Cotesta, L. Zinnamosca, E. Crescenzi, C. Marinelli, M. Saponara, C. Letizia, Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 11, 165\u2013172 (2010)","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"9553_CR25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ncpneph0626","volume":"3","author":"RD Gordon","year":"2007","unstructured":"R.D. Gordon, M. Stowasser, Primary aldosteronism: the case for screening. Nat Clin Pract Nephrol 3, 582\u2013583 (2007)","journal-title":"Nat Clin Pract Nephrol"},{"key":"9553_CR26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/HYPERTENSIONAHA.106.086116","volume":"50","author":"DA Calhoun","year":"2007","unstructured":"D.A. Calhoun, Is there an unrecognized epidemic of primary aldosteronism? (Pro). Hypertension 50, 447\u2013453 (2007). discussion 447\u201353","journal-title":"Hypertension"},{"key":"9553_CR27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/HYPERTENSIONAHA.106.086124","volume":"50","author":"NM Kaplan","year":"2007","unstructured":"N.M. Kaplan, Is there an unrecognized epidemic of primary aldosteronism? (Con). Hypertension 50, 454\u2013458 (2007). discussion 454\u20138","journal-title":"Hypertension"},{"key":"9553_CR28","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"J.W. Funder, R.M. Carey, C. Fardella, C.E. Gomez-Sanchez, F. Mantero, M. Stowasser, W. F. Young Jr., V.M. Montori, Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 3266\u20133281 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9553_CR29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","volume":"2","author":"M Stowasser","year":"2001","unstructured":"M. Stowasser, R.D. Gordon, J.C. Rutherford, N.Z. Nikwan, N. Daunt, G.J. Slater, Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2, 156\u2013169 (2001)","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"9553_CR30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03349761","volume":"18","author":"RD Gordon","year":"1995","unstructured":"R.D. Gordon, Primary aldosteronism. J. Endocrinol. Invest. 18, 495\u2013511 (1995)","journal-title":"J. Endocrinol. Invest."},{"key":"9553_CR31","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"P. Mulatero, F. Rabbia, A. Milan, C. Paglieri, F. Morello, L. Chiandussi, F. Veglio, Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension 40, 897\u2013902 (2002)","journal-title":"Hypertension"},{"key":"9553_CR32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","volume":"217","author":"M Stowasser","year":"2004","unstructured":"M. Stowasser, R.D. Gordon, Primary aldosteronism\u2014careful investigation is essential and rewarding. Mol. Cell. Endocrinol. 217, 33\u201339 (2004)","journal-title":"Mol. Cell. Endocrinol."},{"key":"9553_CR33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","volume":"55","author":"DJ Campbell","year":"2009","unstructured":"D.J. Campbell, J. Nussberger, M. Stowasser, A.H. Danser, A. Morganti, E. Frandsen, J. Menard, Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement. Clin. Chem. 55, 867\u2013877 (2009)","journal-title":"Clin. Chem."},{"key":"9553_CR34","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1210\/jc.2010-2918","volume":"96","author":"AH Ahmed","year":"2011","unstructured":"A.H. Ahmed, R.D. Gordon, P.J. Taylor, G. Ward, E. Pimenta, M. Stowasser, Effect of contraceptives on aldosterone\/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration. J J Clin Endocrinol Metab 96, 1797\u20131804 (2011)","journal-title":"J J Clin Endocrinol Metab"},{"key":"9553_CR35","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jcem-63-4-1008","volume":"63","author":"FH Derkx","year":"1986","unstructured":"F.H. Derkx, C. Steunkel, M.P. Schalekamp, W. Visser, I.H. Huisveld, M.A. Schalekamp, Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. J. Clin. Endocrinol. Metab. 63, 1008\u20131015 (1986)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9553_CR36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0002-8703(84)90144-3","volume":"107","author":"SZ Goldhaber","year":"1984","unstructured":"S.Z. Goldhaber, C.H. Hennekens, R.F. Spark, D.A. Evans, B. Rosner, J.O. Taylor, E.H. Kass, Plasma renin substrate, renin activity, and aldosterone levels in a sample of oral contraceptive users from a community survey. Am. Heart J. 107, 119\u2013122 (1984)","journal-title":"Am. Heart J."},{"key":"9553_CR37","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1210\/jc.2010-2603","volume":"96","author":"AH Ahmed","year":"2011","unstructured":"A.H. Ahmed, M. Calvird, R.D. Gordon, P.J. Taylor, G. Ward, E. Pimenta, R. Young, M. Stowasser, Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone\/renin ratio in normotensive depressed male patients. J. Clin. Endocrinol. Metab. 96, 1039\u20131045 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9553_CR38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1521-690X(03)00050-2","volume":"17","author":"M Stowasser","year":"2003","unstructured":"M. Stowasser, R.D. Gordon, Primary aldosteronism. Best Pract Res Clin Endocrinol Metab 17, 591\u2013605 (2003)","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9553_CR39","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/HJH.0b013e3283060f0c","volume":"26","author":"E Letavernier","year":"2008","unstructured":"E. Letavernier, S. Peyrard, L. Amar, F. Zinzindohoue, B. Fiquet, P.F. Plouin, Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J. Hypertens. 26, 1816\u20131823 (2008)","journal-title":"J. Hypertens."},{"key":"9553_CR40","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1210\/jc.85.8.2854","volume":"85","author":"KC Loh","year":"2000","unstructured":"K.C. Loh, E.S. Koay, M.C. Khaw, S.C. Emmanuel, W. F. Young Jr, Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J. Clin. Endocrinol. Metab. 85, 2854\u20132859 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9553_CR41","first-page":"447","volume":"21","author":"GP Rossi","year":"2008","unstructured":"G.P. Rossi, T.M. Seccia, A.C. Pessina, Primary aldosteronism\u2014part I: prevalence, screening, and selection of cases for adrenal vein sampling. J Nephrol 21, 447\u2013454 (2008)","journal-title":"J Nephrol"},{"key":"9553_CR42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00019616-199707040-00003","volume":"7","author":"WFJ Young","year":"1997","unstructured":"W.F.J. Young, Primary aldosteronism: update on diagnosis and treatment. Endocrinologist 7, 213\u2013221 (1997)","journal-title":"Endocrinologist"},{"key":"9553_CR43","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1161\/HYPERTENSIONAHA.107.093468","volume":"50","author":"P Mulatero","year":"2007","unstructured":"P. Mulatero, C. Bertello, C. Garrone, D. Rossato, G. Mengozzi, A. Verhovez, F. Fallo, F. Veglio, Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension 50, e26\u2013e27 (2007)","journal-title":"Hypertension"},{"key":"9553_CR44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","volume":"50","author":"GP Rossi","year":"2007","unstructured":"G.P. Rossi, A. Belfiore, G. Bernini, G. Desideri, B. Fabris, C. Ferri, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, M. Mannelli, G. Palumbo, D. Rizzoni, E. Rossi, E. Agabiti-Rosei, A.C. Pessina, F. Mantero, Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50, 424\u2013431 (2007)","journal-title":"Hypertension"},{"key":"9553_CR45","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/jc.2009-1399","volume":"94","author":"M Stowasser","year":"2009","unstructured":"M. Stowasser, Update in primary aldosteronism. J. Clin. Endocrinol. Metab. 94, 3623\u20133630 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9553_CR46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archsurg.141.5.497","volume":"141","author":"FE Nwariaku","year":"2006","unstructured":"F.E. Nwariaku, B.S. Miller, R. Auchus, S. Holt, L. Watumull, B. Dolmatch, S. Nesbitt, W. Vongpatanasin, R. Victor, F. Wians, E. Livingston, W. H. Snyder 3rd, Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch. Surg. 141, 497\u2013502 (2006). discussion 502\u20133","journal-title":"Arch. Surg."},{"key":"9553_CR47","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young","year":"2004","unstructured":"W.F. Young, A.W. Stanson, G.B. Thompson, C.S. Grant, D.R. Farley, J.A. van Heerden, Role for adrenal venous sampling in primary aldosteronism. Surgery 136, 1227\u20131235 (2004)","journal-title":"Surgery"},{"issue":"Suppl 1","key":"9553_CR48","doi-asserted-by":"crossref","first-page":"83s","DOI":"10.1016\/S0753-3322(00)80019-0","volume":"54","author":"T Nishikawa","year":"2000","unstructured":"T. Nishikawa, M. Omura, Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed. Pharmacother. 54(Suppl 1), 83s\u201385s (2000)","journal-title":"Biomed. Pharmacother."},{"key":"9553_CR49","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/meta.2002.30498","volume":"51","author":"M Omura","year":"2002","unstructured":"M. Omura, H. Sasano, T. Fujiwara, K. Yamaguchi, T. Nishikawa, Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metabolism 51, 350\u2013355 (2002)","journal-title":"Metabolism"},{"key":"9553_CR50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","volume":"151","author":"MJ Kempers","year":"2009","unstructured":"M.J. Kempers, J.W. Lenders, L. van Outheusden, G.J. van der Wilt, L.J. Schultze Kool, A.R. Hermus, J. Deinum, Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann. Intern. Med. 151, 329\u2013337 (2009)","journal-title":"Ann. Intern. Med."},{"key":"9553_CR51","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jc.86.3.1083","volume":"86","author":"GP Rossi","year":"2001","unstructured":"G.P. Rossi, A. Sacchetto, M. Chiesura-Corona, R. De Toni, M. Gallina, G.P. Feltrin, A.C. Pessina, Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J. Clin. Endocrinol. Metab. 86, 1083\u20131090 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9553_CR52","doi-asserted-by":"crossref","unstructured":"C. Plank, F. Wolf, H. Langenberger, C. Loewe, M. Schoder and J. Lammer, Adrenal venous sampling using Dyna-CT-A practical guide. Eur J Radiol (2011)","DOI":"10.1016\/j.ejrad.2011.05.011"},{"key":"9553_CR53","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.hjh.0000202818.10459.96","volume":"24","author":"GP Rossi","year":"2006","unstructured":"G.P. Rossi, C. Ganzaroli, D. Miotto, R. De Toni, G. Palumbo, G.P. Feltrin, F. Mantero, A.C. Pessina, Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J. Hypertens. 24, 371\u2013379 (2006)","journal-title":"J. Hypertens."},{"key":"9553_CR54","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/HYPERTENSIONAHA.108.128553","volume":"53","author":"TM Seccia","year":"2009","unstructured":"T.M. Seccia, D. Miotto, R. De Toni, G. Pitter, F. Mantero, A.C. Pessina, G.P. Rossi, Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension 53, 761\u2013766 (2009)","journal-title":"Hypertension"},{"key":"9553_CR55","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00423-010-0681-7","volume":"395","author":"J Hennings","year":"2010","unstructured":"J. Hennings, A. Sundin, A. Hagg, P. Hellman, 11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism. Langenbecks Arch Surg 395, 963\u2013967 (2010)","journal-title":"Langenbecks Arch Surg"},{"key":"9553_CR56","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","volume":"144","author":"WF Young Jr","year":"2003","unstructured":"W. F. Young Jr, Minireview: primary aldosteronism\u2014changing concepts in diagnosis and treatment. Endocrinology 144, 2208\u20132213 (2003)","journal-title":"Endocrinology"},{"key":"9553_CR57","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ajh.2010.169","volume":"23","author":"LA Sechi","year":"2010","unstructured":"L.A. Sechi, G. Colussi, A. Di Fabio, C. Catena, Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment. Am. J. Hypertens. 23, 1253\u20131260 (2010)","journal-title":"Am. J. Hypertens."},{"key":"9553_CR58","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1210\/jc.2011-0138","volume":"96","author":"AH Ahmed","year":"2011","unstructured":"A.H. Ahmed, R.D. Gordon, N. Sukor, E. Pimenta, M. Stowasser, Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and\/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically. J. Clin. Endocrinol. Metab. 96, 2904\u20132911 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9553_CR59","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","volume":"95","author":"N Sukor","year":"2010","unstructured":"N. Sukor, C. Kogovsek, R.D. Gordon, D. Robson, M. Stowasser, Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J. Clin. Endocrinol. Metab. 95, 1360\u20131364 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9553_CR60","doi-asserted-by":"crossref","first-page":"E878","DOI":"10.1210\/jc.2010-2723","volume":"96","author":"N Sonino","year":"2011","unstructured":"N. Sonino, E. Tomba, M.L. Genesia, C. Bertello, P. Mulatero, F. Veglio, G.A. Fava, F. Fallo, Psychological assessment of primary aldosteronism: a controlled study. J. Clin. Endocrinol. Metab. 96, E878\u2013E883 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9553_CR61","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s002689900552","volume":"22","author":"JC Rutherford","year":"1998","unstructured":"J.C. Rutherford, W.L. Taylor, M. Stowasser, R.D. Gordon, Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production. World J. Surg. 22, 1243\u20131245 (1998)","journal-title":"World J. Surg."},{"key":"9553_CR62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1994.tb02520.x","volume":"21","author":"M Stowasser","year":"1994","unstructured":"M. Stowasser, S.A. Klemm, T.J. Tunny, W.J. Storie, J.C. Rutherford, R.D. Gordon, Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness. Clin. Exp. Pharmacol. Physiol. 21, 319\u2013322 (1994)","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"9553_CR63","first-page":"1995","volume":"10","author":"NE Jacobsen","year":"2003","unstructured":"N.E. Jacobsen, J.B. Campbell, M.G. Hobart, Laparoscopic versus open adrenalectomy for surgical adrenal disease. Can J Urol 10, 1995\u20131999 (2003)","journal-title":"Can J Urol"},{"key":"9553_CR64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000313480206800307","volume":"68","author":"H Rossi","year":"2002","unstructured":"H. Rossi, A. Kim, R.A. Prinz, Primary hyperaldosteronism in the era of laparoscopic adrenalectomy. Am. Surg. 68, 253\u2013256 (2002). discussion 256\u20137","journal-title":"Am. Surg."},{"key":"9553_CR65","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s002689900115","volume":"20","author":"JC Rutherford","year":"1996","unstructured":"J.C. Rutherford, M. Stowasser, T.J. Tunny, S.A. Klemm, R.D. Gordon, Laparoscopic adrenalectomy. World J. Surg. 20, 758\u2013760 (1996). discussion 761","journal-title":"World J. Surg."},{"key":"9553_CR66","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/bmj.2.5816.729","volume":"2","author":"JJ Brown","year":"1972","unstructured":"J.J. Brown, D.L. Davies, J.B. Ferriss, R. Fraser, E. Haywood, A.F. Lever, J.I. Robertson, Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin. Br. Med. J. 2, 729\u2013734 (1972)","journal-title":"Br. Med. J."},{"key":"9553_CR67","first-page":"995","volume":"80","author":"JY Pagny","year":"1987","unstructured":"J.Y. Pagny, G. Chatellier, J.M. Duclos, P.F. Plouin, P. Corvol, J. Menard, Results of the surgical treatment of Conn\u2019s adenomas. Archives des Maladies du Coeur et des Vaisseaux 80, 995\u2013998 (1987)","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"key":"9553_CR68","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1067\/msy.1998.93108","volume":"124","author":"CA Proye","year":"1998","unstructured":"C.A. Proye, E.A. Mulliez, B.M. Carnaille, M. Lecomte-Houcke, M. Decoulx, J.L. Wemeau, J. Lefebvre, A. Racadot, O. Ernst, D. Huglo, A. Carre, Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism? Surgery 124, 1128\u20131133 (1998)","journal-title":"Surgery"},{"key":"9553_CR69","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0272-6386(05)80002-2","volume":"37","author":"Y Horita","year":"2001","unstructured":"Y. Horita, T. Inenaga, H. Nakahama, H. Ishibashi-Ueda, Y. Kawano, S. Nakamura, T. Horio, N. Okuda, M. Ando, S. Takishita, Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism. Am. J. Kidney Dis. 37, 884\u2013889 (2001)","journal-title":"Am. J. Kidney Dis."},{"key":"9553_CR70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1291\/hypres.25.11","volume":"25","author":"Y Fukudome","year":"2002","unstructured":"Y. Fukudome, K. Fujii, H. Arima, Y. Ohya, T. Tsuchihashi, I. Abe, M. Fujishima, Discriminating factors for recurrent hypertension in patients with primary aldosteronism after adrenalectomy. Hypertens. Res. 25, 11\u201318 (2002)","journal-title":"Hypertens. Res."},{"key":"9553_CR71","first-page":"987","volume":"112","author":"T Obara","year":"1992","unstructured":"T. Obara, Y. Ito, T. Okamoto, Y. Kanaji, T. Yamashita, M. Aiba, Y. Fujimoto, Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery 112, 987\u2013993 (1992)","journal-title":"Surgery"},{"key":"9553_CR72","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/BF02067355","volume":"16","author":"G Favia","year":"1992","unstructured":"G. Favia, F. Lumachi, V. Scarpa, D.F. D\u2019Amico, Adrenalectomy in primary aldosteronism: a long-term follow-up study in 52 patients. World J. Surg. 16, 680\u2013683 (1992). discussion 683\u20134","journal-title":"World J. Surg."},{"key":"9553_CR73","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/110241599750007027","volume":"165","author":"P Sapienza","year":"1999","unstructured":"P. Sapienza, A. Cavallaro, Persistent hypertension after removal of adrenal tumours. Eur. J. Surg. 165, 187\u2013192 (1999)","journal-title":"Eur. J. Surg."},{"key":"9553_CR74","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00000658-199608000-00003","volume":"224","author":"CY Lo","year":"1996","unstructured":"C.Y. Lo, P.C. Tam, A.W. Kung, K.S. Lam, J. Wong, Primary aldosteronism. Results of surgical treatment. Ann. Surg. 224, 125\u2013130 (1996)","journal-title":"Ann. Surg."},{"key":"9553_CR75","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00000658-199404000-00004","volume":"219","author":"RJ Weigel","year":"1994","unstructured":"R.J. Weigel, S.A. Wells, J.C. Gunnells, G.S. Leight, Surgical treatment of primary hyperaldosteronism. Ann. Surg. 219, 347\u2013352 (1994)","journal-title":"Ann. Surg."},{"key":"9553_CR76","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","volume":"135","author":"AM Sawka","year":"2001","unstructured":"A.M. Sawka, W.F. Young, G.B. Thompson, C.S. Grant, D.R. Farley, C. Leibson, J.A. van Heerden, Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann. Intern. Med. 135, 258\u2013261 (2001)","journal-title":"Ann. Intern. Med."},{"key":"9553_CR77","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","volume":"60","author":"X Jeunemaitre","year":"1987","unstructured":"X. Jeunemaitre, G. Chatellier, C. Kreft-Jais, A. Charru, C. DeVries, P.F. Plouin, P. Corvol, J. Menard, Efficacy and tolerance of spironolactone in essential hypertension. Am. J. Cardiol. 60, 820\u2013825 (1987)","journal-title":"Am. J. Cardiol."},{"key":"9553_CR78","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","volume":"15","author":"MH Weinberger","year":"2002","unstructured":"M.H. Weinberger, B. Roniker, S.L. Krause, R.J. Weiss, Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. Am. J. Hypertens. 15, 709\u2013716 (2002)","journal-title":"Am. J. Hypertens."},{"key":"9553_CR79","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","volume":"240","author":"M Gasparo de","year":"1987","unstructured":"M. de Gasparo, U. Joss, H.P. Ramjoue, S.E. Whitebread, H. Haenni, L. Schenkel, C. Kraehenbuehl, M. Biollaz, J. Grob, J. Schmidlin et al., Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro. J. Pharmacol. Exp. Ther. 240, 650\u2013656 (1987)","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"9553_CR80","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/14656566.9.4.509","volume":"9","author":"A Karagiannis","year":"2008","unstructured":"A. Karagiannis, K. Tziomalos, A. Papageorgiou, A.I. Kakafika, E.D. Pagourelias, P. Anagnostis, V.G. Athyros, D.P. Mikhailidis, Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opin Pharmacother 9, 509\u2013515 (2008)","journal-title":"Expert Opin Pharmacother"},{"key":"9553_CR81","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","volume":"29","author":"HK Parthasarathy","year":"2011","unstructured":"H.K. Parthasarathy, J. Menard, W.B. White, W. F. Young Jr., G.H. Williams, B. Williams, L.M. Ruilope, G.T. McInnes, J.M. Connell, T.M. MacDonald, A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. J. Hypertens. 29, 980\u2013990 (2011)","journal-title":"J. Hypertens."},{"key":"9553_CR82","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/clpt.1982.9","volume":"31","author":"GT Griffing","year":"1982","unstructured":"G.T. Griffing, A.G. Cole, S.A. Aurecchia, B.H. Sindler, P. Komanicky, J.C. Melby, Amiloride in primary hyperaldosteronism. Clin. Pharmacol. Ther. 31, 56\u201361 (1982)","journal-title":"Clin. Pharmacol. Ther."},{"key":"9553_CR83","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3109\/10641968309081808","volume":"5","author":"GT Griffing","year":"1983","unstructured":"G.T. Griffing, J.C. Melby, The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism. Clin Exp Hypertens A Theory Practice 5, 779\u2013801 (1983)","journal-title":"Clin Exp Hypertens A Theory Practice"},{"issue":"Suppl 7","key":"9553_CR84","doi-asserted-by":"crossref","first-page":"289s","DOI":"10.1042\/cs061289s","volume":"61","author":"F Mantero","year":"1981","unstructured":"F. Mantero, F. Fallo, G. Opocher, D. Armanini, M. Boscaro, C. Scaroni, Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. Clin Sci (London) 61(Suppl 7), 289s\u2013293s (1981)","journal-title":"Clin Sci (London)"},{"key":"9553_CR85","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1358\/mf.2001.23.3.627950","volume":"23","author":"S Zacharieva","year":"2001","unstructured":"S. Zacharieva, I. Atanassova, E. Natchev, M. Orbetzova, D. Tzingilev, Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension. Methods Find. Exp. Clin. Pharmacol. 23, 153\u2013156 (2001)","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"9553_CR86","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/pgmj.75.882.235","volume":"75","author":"MJ Brown","year":"1999","unstructured":"M.J. Brown, R.V. Hopper, Calcium-channel blockade can mask the diagnosis of Conn\u2019s syndrome. Postgrad. Med. J. 75, 235\u2013236 (1999)","journal-title":"Postgrad. Med. J."},{"key":"9553_CR87","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/HYPERTENSIONAHA.109.146613","volume":"55","author":"P Mulatero","year":"2010","unstructured":"P. Mulatero, C. Bertello, N. Sukor, R. Gordon, D. Rossato, N. Daunt, D. Leggett, G. Mengozzi, F. Veglio, M. Stowasser, Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension 55, 667\u2013673 (2010)","journal-title":"Hypertension"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-011-9553-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-011-9553-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-011-9553-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T18:11:04Z","timestamp":1741889464000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-011-9553-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["9553"],"URL":"https:\/\/doi.org\/10.1007\/s12020-011-9553-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,1]]}}}